Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis

BACKGROUND: Uncertainty regarding clopidogrel effectiveness attenuation because of a drug-drug interaction with proton pump inhibitors (PPI) has led to conflicting guidelines on concomitant therapy. In particular, the effect of this interaction in patients who undergo a percutaneous coronary interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Serbin, Michael A., Guzauskas, Gregory F., Veenstra, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141192/
https://www.ncbi.nlm.nih.gov/pubmed/27459657
http://dx.doi.org/10.18553/jmcp.2016.22.8.939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141192/
https://www.ncbi.nlm.nih.gov/pubmed/27459657
http://dx.doi.org/10.18553/jmcp.2016.22.8.939

Ejemplares similares